Cooperative Study of Factor VIII Inhibitors

• Status: Completed
• Trial end date: 1979-07-01
• Target enrollment: 0
• Participant gender: Male

Summary

To test the efficacy of prothrombin complex concentrates (Factor IX) in the treatment of hemophiliac patients who had inhibitors to Factor VIII.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Criteria

Males with hemophilia, not stratified as to ethnic group.